EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacological functions of salidroside in renal diseases: facts and perspectives

Qiong Liu, Jianzhu Chen, Anqi Zeng, Linjiang Song

Frontiers in Pharmacology · 08.01.2024 · 14

DOI: 10.3389/fphar.2023.1309598 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.01.2024. Verfasst von Qiong Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rhodiola rosea is a valuable functional medicinal plant widely utilized in China and other Asian countries for its anti-fatigue, anti-aging, and altitude sickness prevention properties. Salidroside, a most active constituent derived from Rhodiola rosea , exhibits potent antioxidative, hypoxia-resistant, anti-inflammatory, anticancer, and anti-aging effects that have garnered significant attention. The appreciation of the pharmacological role of salidroside has burgeoned over the last decade, making it a beneficial option for the prevention and treatment of multiple diseases, including atherosclerosis, Alzheimer’s disease, Parkinson’s disease, cardiovascular disease, and more. With its anti-aging and renoprotective effects, in parallel with the inhibition of oxidative stress and inflammation, salidroside holds promise as a potential therapeutic agent for kidney damage. This article provides an overview of the microinflammatory state in kidney disease and discuss the current therapeutic strategies, with a particular focus on highlighting the recent advancements in utilizing salidroside for renal disease. The potential mechanisms of action of salidroside are primarily associated with the regulation of gene and protein expression in glomerular endothelial cells, podocytes, renal tubule cells, renal mesangial cells and renal cell carcinoma cell, including TNF-α, TGF-β, IL-1β, IL-17A, IL-6, MCP-1, Bcl-2, VEGF, ECM protein, caspase-3, HIF-1α, BIM, as well as the modulation of AMPK/SIRT1, Nrf2/HO-1, Sirt1/PGC-1α, ROS/Src/Cav-1, Akt/GSK-3β, TXNIP-NLRP3, ERK1/2, TGF-β1/Smad2/3, PI3K/Akt, Wnt1/Wnt3a β-catenin, TLR4/NF-κB, MAPK, JAK2/STAT3, SIRT1/Nrf2 pathways. To the best of our knowledge, this review is the first to comprehensively cover the protective effects of salidroside on diverse renal diseases, and suggests that salidroside has great potential to be developed as a drug for the prevention and treatment of metabolic syndrome, cardiovascular and cerebrovascular diseases and renal complications.

Schlagwörter

Stichwörter der Autor:innen

acute kidney injurydiabetic nephropathyinflammationrenal cell carcinomarenal interstitial fibrosissalidroside

Autor:innen und Institutionen

  • School of Medical and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
  • Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Chinese Medicine Sciences, Sichuan Institute for Translational Chinese Medicine, Chengdu, Sichuan, China.

Zitieren

APA

Liu, Q., Chen, J., Zeng, A., & Song, L. (2024). Pharmacological functions of salidroside in renal diseases: facts and perspectives. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1309598

Vancouver

Liu Q, Chen J, Zeng A, Song L. Pharmacological functions of salidroside in renal diseases: facts and perspectives. Frontiers in Pharmacology. 2024;14. doi:10.3389/fphar.2023.1309598

BibTeX
@article{Liu2024,
  author = {Liu, Qiong and Chen, Jianzhu and Zeng, Anqi and Song, Linjiang},
  title = {Pharmacological functions of salidroside in renal diseases: facts and perspectives},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fphar.2023.1309598}
}
Kostenlos starten →